Clinical trials of arsenic trioxide in hematologic and slid tumors: Overview of the national cancer institute cooperative research and development studies

被引：175

作者：

Murgo, AJ ^{[1
]}

机构：

[1] NCI, Invest Drug Branch, Canc Therapy Evaluat Program, NIH, Rockville, MD 20852 USA

来源：

ONCOLOGIST | 2001年 / 6卷

关键词：

arsenic trioxide; Nnational Cancer Institute; hematologic malignancy; solid tumor;

D O I：

10.1634/theoncologist.6-suppl_2-22

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Arsenic trioxide inhibits growth and promotes apoptosis in many different cancer cell lines. The National Cancer Institute is working cooperatively with research centers across the U.S. to evaluate its clinical activity in hematologic malignancies, such as acute promyelocytic leukemia, acute myeloid leukemia, acute lymphocytic leukemia, chronic myelogenous leukemia, non-Hodgkin's lymphoma, Hodgkin's disease, chronic lymphocytic leukemia, myelodysplastic syndrome, and multiple myeloma. It is also supporting research in solid tumors, such as advanced hormone-refractory prostate cancer and renal cell cancer and in cervical cancer and refractory transitional cell carcinoma of the bladder. The safety and pharmacokinetics of arsenic trioxide are also being evaluated in pediatric patients with refractory leukemia and lymphoma. The results of these ongoing studies should provide important insights into the clinical utility of arsenic trioxide in these diseases.

引用

页码：22 / 28

页数：7

共 28 条

[21]

Tang B, 1998, BLOOD, V92, p638A

[22] Arsenic trioxide and melarsoprol induce programmed cell death in myeloid leukemia cell lines and function in a PML and PML-RARα independent manner [J].

Wang, ZG ;

Rivi, R ;

Delva, L ;

König, A ;

Scheinberg, DA ;

Gambacorti-Passerini, C ;

Gabrilove, JL ;

Warrell, RP ;

Pandolfi, PP .

BLOOD, 1998, 92 (05) :1497-1504

[23]

Yang C. H., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P227

[24] The induction of apoptosis and cell cycle arrest by arsenic trioxide in lymphoid neoplasms [J].

Zhang, W ;

Ohnishi, K ;

Shigeno, K ;

Fujisawa, S ;

Naito, K ;

Nakamura, S ;

Takeshita, K ;

Takeshita, A ;

Ohno, R .

LEUKEMIA, 1998, 12 (09) :1383-1391

[25]

Zheng J, 1999, INT J CANCER, V82, P286, DOI 10.1002/(SICI)1097-0215(19990719)82:2<286::AID-IJC21>3.0.CO

[26]

2-K

[27]

Zhou D.-C., 1998, Proceedings of the American Association for Cancer Research Annual Meeting, V39, P588

[28] Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations [J].

Zhu, XH ;

Shen, YL ;

Jing, YK ;

Cai, X ;

Jia, PM ;

Huang, Y ;

Tang, W ;

Shi, GY ;

Sun, YP ;

Dai, J ;

Wang, ZY ;

Chen, SJ ;

Zhang, TD ;

Waxman, S ;

Chen, Z ;

Chen, GQ .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (09) :772-778

← 1 2 3 →